Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:age-related_macular_degeneration
gptkb:disease |
| gptkbp:affects |
retina
macula |
| gptkbp:affectsDemographic |
elderly
Caucasians more than other races |
| gptkbp:alternativeName |
dry age-related macular degeneration
atrophic AMD nonexudative AMD |
| gptkbp:associatedWith |
oxidative stress
chronic inflammation |
| gptkbp:cause |
vision loss
central vision impairment |
| gptkbp:characterizedBy |
drusen accumulation
retinal pigment epithelium atrophy |
| gptkbp:complication |
gptkb:geographic_atrophy
legal blindness |
| gptkbp:diagnosedBy |
gptkb:optical_coherence_tomography
fundus photography dilated eye exam Amsler grid |
| gptkbp:distinctiveFeature |
gptkb:wet_AMD
|
| gptkbp:firstDescribed |
early 20th century
|
| gptkbp:hasNoCure |
true
|
| gptkbp:hasNoFluidLeakage |
true
|
| gptkbp:prevalence |
accounts for 85-90% of AMD cases
most common form of AMD |
| gptkbp:progression |
slow
can progress to wet AMD |
| gptkbp:riskFactor |
age
family history obesity smoking hypertension high cholesterol light eye color |
| gptkbp:studiedBy |
ophthalmology
|
| gptkbp:symptom |
blurred vision
difficulty recognizing faces difficulty reading need for brighter light decreased intensity or brightness of colors difficulty adapting to low light increased blurriness of printed words |
| gptkbp:treatment |
lifestyle modification
low vision aids AREDS2 supplements |
| gptkbp:bfsParent |
gptkb:wet_AMD
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
dry AMD
|